Open Access Green as soon as Postprint is submitted to ZB.
Defining new pancreatic tumour entities by molecular analysis.
Pancreatol. 9, 334-339 (2009)
Recent advances in molecular biology, biochemistry and genetics have broadened our understanding of tumourigenesis and of the maintenance and spread of pancreatic cancer far beyond traditional microscopic histopathological analysis. While the main focus of pancreatic cancer research has been on pancreatic ductal adenocarcinoma, molecular research has also led to a better understanding of rare tumours of the pancreas, as well as to the definition of previously unknown tumour entities that can only be identified through the application of molecular tools. Furthermore, molecular analysis increasingly reveals the genetic and cell biological heterogeneity of established tumour entities, making sub-classification of tumours possible. Genetic and molecular approaches may, therefore, not only lead to a better understanding of the pathogenesis of pancreatic tumours, but also culminate in more precise diagnosis as well as individually tailored treatment strategies for affected patients.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
3.043
1.240
3
3
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Review
Keywords
Pancreatic cancer; Tumour entities; Molecular analysis; Mutation; mucinous cystic neoplasms; ras gene-mutations; intraepithelial neoplasia; aberrant methylation; immunohistochemical analysis; ductal adenocarcinoma; clinical-implications; precursor lesions; cell-carcinoma; p53 protein
Language
english
Publication Year
2009
HGF-reported in Year
2009
ISSN (print) / ISBN
1424-3903
e-ISSN
1424-3911
Journal
Pancreatology
Quellenangaben
Volume: 9,
Issue: 4,
Pages: 334-339
Publisher
Elsevier
Publishing Place
BASEL
Reviewing status
Peer reviewed
Institute(s)
Institute of Pathology (PATH)
POF-Topic(s)
30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
Research field(s)
Enabling and Novel Technologies
PSP Element(s)
G-500300-001
Scopus ID
65649120817
PubMed ID
19451742
Erfassungsdatum
2009-12-31